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Several authors have considered the importance of exposure timing and how this affects the
outcomes observed, but no one has systematically compiled preconceptional, prenatal, and
postnatal developmental exposures and subsequent outcomes. Efforts were undertaken to
examine the information available and to evaluate implications for risk assessment for several areas:
a) respiratory and immune systems, b) reproductive system, c) nervous system, d) cardiovascular
system, endocrine system, and general growth, and e) cancer. Major conclusions from a workshop
on "Critical Windows of Exposure for Children's Health" included a) broad windows of sensitivity
can be identified for many systems but detailed information is limited; b) cross-species comparisons
of dose to target tissue and better data on the exposure-dose-outcome continuum are needed; c)
increased interaction among scientific disciplines can further understanding by using laboratory
animal results in designing epidemiological studies and human data to suggest specific laboratory
studies on mechanisms and agent-target interactions; and d) thus far, only limited attention has
been given to peripubertal/adolescent exposures, adult consequences of developmental exposures,
and genome-environment interactions. More specific information on developmental windows will
improve risk assessment by identifying the most sensitive window(s) for evaluation of
dose-response relationships and exposure, evaluation of biological plausibility of research findings
in humans, and comparison of data across species. In public health and risk management,
information on critical windows may help identify especially susceptible subgroups for specific
interventions. Key words: children's health, developmental disorders, developmental toxicity,
environmental health, risk assessment, teratogen, windows of vulnerability. - Environ Health
Perspect 108(suppl 3):451-455 (2000).
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In a discussion of "highly susceptible
period[s] of organogenesis," Wilson (1)
described the importance ofexposure timing
within the developing organism, and howthis
ultimately affects the outcomes observed. His
hypothetical example, limited to prenatal
exposures, showed that the same exposure at
different times would create a different spec-
trum of, in this case, malformations due to
the timing of the development of different
organ systems (Figure 1). Other authors have
considered the importance ofcritical periods
ofvulnerability in the developing organism.
For example, Rodier (2) presented a summary
ofexperimental data on timing ofneuron ori-
gin in the developing mouse brain (Figure 2).
A time line for human development (Figure
3) identified highly sensitive windows for
morphological abnormalities and compared
them to less sensitive times that were more
likely to be associated with physiological
defects and minor morphological abnormali-
ties (3). Later, an adaptation (Figure 4) of
these efforts was made for commonly studied
adverse outcomes for humans, broader than
malformations and physiological defects, but
still limited to preconceptional and prenatal
exposures (4).
The U.S. Environmental Protection
Agency (U.S. EPA) is concerned with the
entire gamut ofdevelopmental exposures and
outcomes, i.e., developmental toxicity.
Developmental toxicity is defined as the
occurrence ofadverse effects on the develop-
ing organism that may result from exposure
prior to conception (either parent), during
prenatal development, or postnatally to the
time ofsexual maturation. Adverse develop-
mental effects may be detected at any point in
the life span ofthe organism. The major man-
ifestations ofdevelopmental toxicity include
death ofthe developing organism, structural
abnormality, altered growth, and functional
deficiency (5). Developmental exposures may
result in health effects observed prenatally and
at birth (such as spontaneous abortion, still-
birth, low birth weight, small for gestational
age, infant mortality, and malformations)
(4,6-8), in childhood (effects such as asthma,
cancer, neurologic and behavioral effects)
(9-12), and as adults and into old age (such as
cancer, heart disease, and degenerative neuro-
logic/behavioral disorders) (13-16).
Several authors have pointed out that little
concrete information exists on critical windows
for exposure during the postnatal period
(17,18). However, a systematic examination
has notyet been done ofavailable data on criti-
cal windows ofvulnerability to agents that may
cause toxicity throughout prenatal and postna-
tal development. Most available data are
focused on prenatal exposures (for example,
maternal medications such as diethylstilbestrol
or thalidomide, and parental alcohol, smoking,
and occupational exposures) (6-11,19-21).
Postnatal exposures have been examined for
only a few agents (e.g., lead, pesticides,
radiation) (12-1i).
The effort reported in this monograph
was undertaken to review the data available
on the various types ofpreconceptional, pre-
natal, and postnatal developmental exposures
and subsequent outcomes; to examine the
state-of-the-science knowledge on critical
windows ofsusceptibility; and finally, to eval-
uate their implications for risk assessment. To
do this, experts were asked to prepare back-
ground papers summarizing current knowl-
edge about critical windows for five topic
areas: a) respiratory and immune systems
(22-24); b) reproductive system (25); c) ner-
vous system (26); and d) cardiovascular sys-
tem, endocrine system, and general growth
(27-29); and e) cancer (30). On 14-15
September 1999, a workshop, "Critical
Windows ofExposure for Children's Health,"
was convened in Richmond, Virginia, with
nearly 60 scientists from a variety ofdisci-
plines. This multidisciplinary group included
expertise in clinical medicine, psychology, tox-
icology, epidemiology, and risk assessment.
Participants were brought together to discuss
current knowledge on critical windows of
exposure, identify major issues for future
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Figure 1. Hypothetical representation of how the
syndrome of malformations produced by a given agent
might be expected to change when treatment is given at
different times. The percentage of animals affected as
well as the incidence rank of the various types of mal-
formations would be somewhat different from that
shown for day 10 if treatment were given instead on day
12 or 14, for example. Reprinted with permission of
University of Chicago Press (1).
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Figure 2.Times of neuron origin in the developing mouse brain. Times are based on autoradiographic studies of
specific structures overtime. Vertical lines at 12 days and 20 days representtheapproximate end of critical period for
gross defects and the time of birth, respectively. Reprinted with permission ofJohnWiley and Sons, Inc. (2).
Figure 3. Schematic illustration of the sensitive or critical periods in human development. Dark gray denotes highly sensitive periods; light gray indicates stages that are less
sensitive to teratogens. Reprinted with permission ofW.B. Saunders Co. [(13; first published in 1973].
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efforts, and determine how this information
can ultimately be used for risk assessment and
public health purposes.
Typically, studies ofhumans have used
broad categories ofexposure covering multi-
ple windows. In laboratory animal studies,
the early literature in experimental teratology
was dominated bystudies aimed at periods of
known high sensitivity for producing certain
types ofmalformations. More contemporary
studies, in particular those done for regula-
tory testing purposes, often include extended
periods to simulate long-term human expo-
sure. For example, in the prenatal develop-
mental toxicity study (31), dosing extends
from implantation to term. Dosing in the
two-generation reproduction study (32) is for
several weeks preconception, then prenatally
and postnatally for two generations. In the
developmental neurotoxicity study (33), dos-
ing usually begins at implantation and con-
tinues throughout prenatal development until
midway through or to completion of the
preweaning period to cover the major periods
of nervous system development. In some
cases, the developmental neurotoxicity study
is combined with the two-generation study
and animals are evaluated in the second gen-
eration. Occasionally, follow-up studies of
short-term exposures are conducted to deter-
mine critical windows ofsensitivity, but this
is rare for environmental chemicals [forexam-
ple, see Narotskyet al. (34)].
In humans, patterns ofexposure are much
more variable. Data on exposures to parents
and children are frequently collected from
"convenience" samples of individuals.
Exposure data are collected at a time conve-
nient for the researchers, often contempora-
neous, but not necessarily at a biologically
plausible time for the health effect.
Alternatively, exposures during the relevant
time frame must be recalled or reconstructed.
Exposure issues vary by life stage (pre-
conception, prenatal, and postnatal).
Important preconceptional exposures could
be a) temporary, limited to those immediately
preceding conception; b) at some earlier time
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Figure 4. Reproductive outcomes associated with timing of maternal exposure. Solid lines indicate the most proba-
ble timing of exposure for a particular outcome; dotted lines indicate less probable but still possible timing of expo-
sure. Arrows suggest that a defined cutoff point for exposure to a specific outcome is not known. Reprinted with
permission ofLippincott, Williams andWilkins(4).
Table 1. Physiologic andtoxicokinetic changes during pregnancy.a
Parameter Physiologic change
Absorption
Gastric emptying time
Intestinal motility
Pulmonary function
Cardiac output
Blood flowto skin
Dermal hydration
Metabolism
Hepatic metabolism
Extrahepatic metabolism
Plasma proteins
Excretion
Renal blood flow
Glomerular filtration rate
Pulmonaryfunction
Plasma proteins
&Modified from Silvaggio etal.(351.
Increased
Decreased
Increased
Increased
Increased
Increased
+/-
+/-
Decreased
Increased
Increased
Increased
Decreased
Toxicokinetic change
Absorption increased
Absorption increased
Pulmonary exposure increased
Absorption increased
Absorption increased
Absorption +/-
Metabolism +/-
Metabolism +/-
Metabolism +/-
Increased renal elimination
Increased renal elimination
Increased pulmonary elimination
Elimination +/-
(prior to conception), creating nonreversible
conditions; or c) consist of an accumulation
of an increased body burden accumulated
over a long period of exposure. Prenatally,
exposures often change throughout preg-
nancy due to choice or necessity. For exam-
ple, women may choose to reduce or quit
smoking, or may do so as a response to physi-
cal symptoms ofpregnancy such as nausea.
Layered on top ofthese variations, changes in
internal dose may result from alterations in
absorption, distribution, metabolism, and
excretion during pregnancy (Table 1) (35).
For example, with the increased pulmonary
function, pregnant women exchange about
72% more air over 8 hr at rest (5,000 L in
pregnant women vs 2,900 L in nonpregnant
women) (36). Studies ofprenatal exposures in
humans frequently obtain one measure of
exposure for the entire pregnancy because the
investigators either assume that the exposure
is consistent over time, or they lack the
resources or sufficiently refined tools to
obtain more detailed information. Additional
issues are raised for studies which, by design,
must estimate exposures retrospectively (e.g.,
case-control studies ofbirth defects). Since
exposure data must be recalled, efforts can be
made to reconstruct changes in exposure
throughout gestation, but the data are subject
to recall bias.
Finally, many studies of postnatal
outcomes collect exposure data at the same
time the child's health status is determined.
Children's exposures change radically over
time. At different developmental stages, the
biology, behavior, and activities ofchildren
(Table 2) result in variable exposures among
children and differences from adults in the
same environment. For example, the surface
area to body mass ratio in infants is approxi-
mately2.7-fold greater than in adults, the res-
piratory minute ventilation rate is more than
65 times greater (36), and consumption of
drinkingwater more than 2 times higher than
adults per body weight (37). Even over the
relatively short time span ofchildhood, these
can vary widely. Thus, exposures identified
concurrently with the observation ofhealth
status may not be similar to those occurring
during the criticalwindow(s) ofexposure.
Because ofa variety offactors, children
have a greater potential for adverse health
effects than adults. Children are still develop-
ing in many ways and may be more vulnera-
ble. They may be less able to rid themselves
ofexposure due to immature mechanisms for
detoxification; and because ofdifferences in
metabolism and behavior, they may reach
higher levels ofexposure within the same
environment as adults. To better identify and
understand the relationships among expo-
sures and developmental outcomes, the first
step is identification ofkey time periods for
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Table2. Differences in children and adults.
Infants Children Teens Adults Reference
Surface area: body mass ratio Newborn Young child Olderchild Adult (35)
(m2/kg) 0.067 0.047 0.033 0.025
Respiratory ventilation rates Infant Adult (35)
Respiratoryvolume(mL/kg/breath) 10 10
Alveolar surface area (n2) 3 75
Respiration rate(breaths/min) 40 15
Respiratory minute
Ventillation ratea 133 2
Drinking water(tap) <1 year 1-10years 11-19years 20-64 years (36)
Mean intake (mL/kg/day) 43.5 35.5 18.2 19.9
Fruitconsumption (g/kg/day) <1 year 3-5years 12-19years 40-69years (37)
Citrus fruits 1.9 2.6 1.1 0.9
Otherfruits(including apples) 12.9 5.8 1.1 1.3
Apples 5.0 3.0 0.4 0.4
Soil ingestion (mg/day) 500 (38)
Pica child
Child age 2.5years Adult
Outdoor 50 20b
Indoor 60 0.4
Differences in GI absorption Age 0-2years Age 2-6years Age 6-7 years Adult
of lead 42-53% 30-40% 18-24% 7-15% (39)
'mL/kg bodyweight/m2 lung surface area/min. bGardening foradults.
specific outcomes. Data on these critical
windows have not been previously compiled
in a structured, systematic manner. The
accompanying reports present the current
understanding ofcritical windows, gaps in
knowledge, the use ofthis information in the
risk assessment process, and recommenda-
tions forfuture activities (41-45).
Some major themes were identified in
these discussions. The first step in identifying
critical windows involved tracking develop-
ment ofthe systems examined. This allowed
identification of times when the system is
potentially most vulnerable to the action of
toxic agents. Current information on the
exact timing and sensitivity during these win-
dows is limited, however. In those cases
where information can be found, there may
not be uniform sensitivity across the window,
reinforcing the importance ofdetailed expo-
sure assessment. For many developmental
events, broad windows have been used,
increasing the likelihood ofmisclassification
ofexposure.
Although most work groups used the
approach described above, the Cancer Work
Group was in a unique situation: They were
addressing an outcome that could affect a
wide variety ofsystems and might have many
windows. The Cancer WorkGroup noted the
importance ofthe development ofa unifying
model, ". . . aholistic pathogenetic model that
encompasses childhood and adult cancers`
(45), to move understanding forward.
The work group discussions identified
similarities in reactions to agents with toxic
potential for humans and laboratory animals.
Some significant differences were also identi-
fied: a) Differences may affect delivery ofan
agent to the target, for example, placenta in
humans versus yolk sac in rodents. b) Some
developmental events occur postnatally in
rodents but occur prenatally in humans; and
the fact that "childhood" is very short in
rodents. Because ofthe inherent differences,
comparisons across species ofthe dose to the
target tissue would be most informative. This
highlights the need for better data on the
exposure-dose-outcome continuum in both
humans and laboratory animals.
The importance ofincreased interaction
among different scientific disciplines was
identified. Laboratory animal data could lead
epidemiologists/clinicians to areas ofpotential
concern in humans, and epidemiologic data
could identify areas for laboratory investiga-
tors to develop mechanistic dataand informa-
tion on agent-target interactions. These
could then feed into the development of
more sensitive methods in both arenas, vali-
dation across species, and ultimate incorpora-
tion into future studies.
Other areas identified for future work
include thefollowing:
While there has been increased interest in
the examination ofchildren's health, only
limited attention has been given to adult
consequences ofdevelopmental exposures.
Not much is known about the potential
cascade ofevents that might result in
adverse outcomes. The association of
developmental exposure with long-term
health outcomes was discussed. For exam-
ple, in the case where intrauterine growth
retardation (IUGR) is associated with
exposure, do those with exposure-related
IUGR have the same later-life sequelae as
individuals with IUGR due to nutritional
orotherdevelopmental factors?
* Are those with certain genetic traits more
likely to get cancer or other health condi-
tions associated with developmental expo-
sures? Limited data are available on
gene-environment interactions, an area
identified as important for future
research.
* The peripubertal/adolescent period was
identified as a life stage underrepresented
in the current literature, despite the fact
that many organ systems undergo signifi-
cant development during this time.
What will these data mean for public
health, risk assessment, and risk management?
In hazard identification/dose-response assess-
ment (5), information about developmental
windows will aid in evaluation ofthe biologi-
cal plausibility ofresearch findings, compari-
son ofdata across species, and identification of
the most sensitive window for the evaluation
ofdose-response relationships and exposure.
In risk management, information on critical
windows mayhelp identifyespecially suscepti-
blesubgroups/ages forspecific interventions.
A consistent picture appears across the
topic areas: more information is needed on
critical windows ofdevelopment to improve
assessment ofpotential environmental health
risks.
Continuing dialogue among scientists
from various disciplines can help in the effort
to fill in the data gaps, improve measurement
ofexposures, and enhance the use ofinforma-
tion on critical windows of exposure to
improve estimates ofriskforchildren's health.
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